Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer

Clinical trial NCT03827473 · TERMINATED

Trial details

NCT number: NCT03827473
Sponsor: University of Utah
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Castration-Sensitive Prostate Carcinoma Metastatic Prostatic Adenocarcinoma Stage IV Prostate Cancer Stage IVA Prostate Cancer Stage IVB Prostate Cancer

Start date: 2019-02-08
Primary completion: 2019-07-31
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.